Evidence map›Paper›PMID 42819940›Full record

ArticleACS omega2026

Screening of Xeroprotectants for Efficient Mammalian Cell Structural Preservation in Dry Conditions.

Valentin Diez-Cabanes, Takahiro Kikawada, Pasqualino Loi, Santiago Aparicio

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Valentin Diez-CabanesInternational Research Center in Critical Raw Materials for Advanced Industrial Technologies (ICCRAM), University of Burgos, Burgos 09001, Spain.ORCID https://orcid.org/0000-0002-6234-2749
Takahiro KikawadaDepartment of Integrated Biosciences, Graduate School of Frontier Science, The University of Tokyo, Kashiwa 277-8562, Chiba, Japan.
Pasqualino LoiDepartment of Veterinary Medicine, University of Teramo, Teramo 64100, Italy.
Santiago AparicioInternational Research Center in Critical Raw Materials for Advanced Industrial Technologies (ICCRAM), University of Burgos, Burgos 09001, Spain.ORCID https://orcid.org/0000-0001-9996-2426

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anhydrobiosis, the ability of organisms to survive extreme conditions such as desiccation, may represent a sustainable alternative to liquid-nitrogen (liquid nitrogen)-based cryopreservation once it can be induced in mammalian cells and germplasm. While natural xeroprotectants (e.g., signature peptides of Late Embryogenesis Abundant proteins and tardigrade disordered proteins, and vitamin E) can stabilize cells under drying, their use is limited to the laboratory level due to the high cost of extraction and the incomplete understanding of the molecular mechanisms. Here we employed a multiscale modeling framework spanning quantum mechanics (QM) and molecular dynamics to investigate how these representative xeroprotectants interact with mammalian model membranes (POPC/DMPC) under desiccation and thermal cycling. We found that peptide-based xeroprotectants remain near headgroups and form dehydration-enhanced hydrogen bonds, whereas vitamin E partitions into the acyl chain region. This is consistent with suppressed pore formation in oxidized membranes. Across dry states, xeroprotectants generally increase acyl chain order and membrane rigidity, attenuate area shrinkage, and preserve bilayer thickness homogeneity. Notably, at higher peptide concentrations, chain overordering is mitigated, suggesting a tunable window for formulation. These results provide physicochemical guidelines for designing cost-effective, eco-friendly, and energy-efficient formulations of xeroprotectants and support the rational development of room-temperature preservation strategies with improved translational potential.

Identifiers

PMID42819940
PMCPMC13625561

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.